Store
Current IVD Market Trends, 2019
Publication Date: October 31, 2019
Tags: Genetic Diseases, Hematology, Histology and Cytology, In Vitro Diagnostics (IVD), Infectious Diseases, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 30
SKU: 19-056
This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:
- Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
- Examination of Genetic Testing Trends
- Insights into New Point-of-Care (POC) Innovations
- Trends in Cancer Testing and Personalized Medicine
- Advancements in Hematology and Glucose Monitoring
- Analysis of HbA1c Testing
- Emerging Developments in Infectious Diseases
- Increasing Molecular Diagnostic Options in Cytology
- Market Dynamics in Blood Bank Markets
- Innovations in Synovial Fluid Testing
- Updates on Transplant Diagnostics
- Focus on Tick-Borne Diseases: Babesiosis and Parasites
- Industry Partnerships and Collaborations
For further details and to purchase directly, please contact us.
Table of Contents
Introduction
-
- Figure 1-1: The Worldwide IVD Market, 2019 -2024 ($millions)
-
- Figure 1-2: Regional Distribution of IVD Market, 2019 (N. America, Europe, Japan, China, RoW)
North America
EU15/Western Europe
Eastern Europe
Japan
China
Genetic Testing
New POC Innovations
Cancer Testing and Personalized Medicine
Hematology
Glucose Monitoring Advancements
HbA1c Testing
New Developments in Infectious Diseases
- Ebola Testing
- Hepatitis C Testing
- HIV Testing
- Molecular Diagnostics Innovations for Infectious Diseases
- Respiratory Viruses
- Sepsis
- STDs
- Zika Virus Testing
Cytology – Increasing Molecular Dx Options
Blood Bank Markets
Synovial Fluid Testing
Transplant Diagnostics
Tick-Borne Diseases
- Babesiosis
Parasites
Latest Industry Activity
- Abbott Diagnostics and Intoximeters
- Agilent Acquires BioTek Instruments
- Adaptive Biotechnologies and Illumina
- AroCell AB and Diapharma Group
- Beckman Coulter and Cytobank
- BGI Genomics and Pryzm Health
- CareDx and Cibiltech
- Exact Sciences Buys Genomic Health
- Illumina and Qiagen Partnership
- Invitae and Singular Bio
- LabCorp Sells Qiagen’s Companion Dx
- NeuMoDx and SelfScreen
- Meridian Bioscience and GenePOC
- Qiagen Launches APIS Assay Technologies, Ltd.
- Qiagen and Inovio Pharmaceuticals
- Qiagen Collaborates with DiaSorin
- Thermo Fisher Scientific and HighChem Ltd.
- Companies Buy to Grow
- Gene Editing
Related products
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
$5,000.00 – $7,500.00
Cell and Gene Therapy Market and Deals Analysis, 2023
May 22, 2023
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…
$4,000.00 – $6,000.00
At-Home Diagnostic Testing Markets and Trends, 2023
June 6, 2023
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…
$4,000.00 – $6,000.00
